Conical-PEP is safe, reduces lung hyperinflation and contributes to improved exercise endurance in patients with COPD: A randomised cross-over trial

Journal of Physiotherapy

Volumn 56, Issue 1, 2010, Pages 33-39

  Padkao, Tadsawiya ^a   Boonsawat, Watchara ^a   Jones, Chulee U ^a  

^a KHON KAEN UNIVERSITY   (Thailand)

Author keywords

Chronic obstructive pulmonary disease; Exercise endurance; Physiotherapy; Positive expiratory pressure; Randomized trial; Total lung capacity

Indexed keywords

ARTICLE; BREATHING MUSCLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DYSPNEA; ENDURANCE; FEMALE; HUMAN; LUNG FUNCTION TEST; MALE; METHODOLOGY; MIDDLE AGED; PATHOPHYSIOLOGY; POSITIVE END EXPIRATORY PRESSURE; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME;

CROSS-OVER STUDIES; DYSPNEA; FEMALE; HUMANS; MALE; MIDDLE AGED; PHYSICAL ENDURANCE; POSITIVE-PRESSURE RESPIRATION; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RESPIRATORY FUNCTION TESTS; RESPIRATORY MUSCLES; TREATMENT OUTCOME;

EID: 77955493824     PISSN: 18369553     EISSN: 18369561     Source Type: Journal    
DOI: 10.1016/S1836-9553(10)70052-7     Document Type: Article

References (25)

1. Armstrong L, Balady GJ, Berry MJ, Davis SE, Davy BM, Davy KP et al (2006) Health-related physical fitness testing and interpretation. In Whaley MH, Brubaker PH, Otto RM (Eds) ACSM's Guidelines for Exercise Testing and Prescription (7th edn). Philadelphia: Lippincott Williams & Wilkins. pp 81-83.
2. Christopher BC. (2006) The connection between chronic obstructive pulmonary disease symptoms and hyperinflation and its impact on Exercise and function. The American Journal of Medicine 119: 21-31.
3. Fregonezi GA, Resqueti VR, Guell Rous R. (2004) Pursed lips breathing. Archivos de bronconeumología 40: 279-282.
4. Knudson RJ, Lebowitz MD, Holberg CJ, Burrows B. (1983) Changes in the normal maximal expiratory flow-volume curve with growth and aging. American Review of Respiratory Disease 127: 725-734.
5. Maltais F, Hamilton A, Marciniuk D, Hernandez P, Sciurba FC, Richter K et al. (2005) Improvements in symptom-limited exercise performance over 8 h with once-daily tiotropium in patients with COPD. Chest 128: 1168-1178.
6. Marini JJ, Crooke PS, Truwit JD. (1989) Determinants and limits of pressure-preset ventilation: a mathematical model of pressure control. Journal of Applied Physiology 67: 1081-1092.
7. Miller MR, Hankinson J, Brusasco V, Burgos F, Casaburi R, Coates A et al. (2005) Standardisation of spirometry. European Respiratory Journal 26: 319-338.
8. Mitchell V. (2007) Gas, tubes and flow. Anaesthesia and Intensive Care Medicine 8: 7-10.
9. O'Donnell DE. (1994) Breathlessness in patients with chronic airflow limitation. Mechanisms and management. Chest 106: 904-912.
10. O'Donnell DE, Banzett RB, Carrieri-Kohlman V, Casaburi R, Davenport PW, Gandevia SC et al. (2007) Pathophysiology of dyspnea in chronic obstructive pulmonary disease: a roundtable. Proceedings of the American Thoracic Society 4: 145-168.
11. O'Donnell DE, Revill SM, Webb KA. (2001) Dynamic hyperinflation and exercise intolerance in chronic obstructive pulmonary disease. American Journal of Respiratory and Critical Care Medicine 164: 770-777.
12. O'Donnell DE, Sanii R, Younes M. (1988) Improvement in exercise endurance in patients with chronic airflow limitation using continuous positive airway pressure. American Review of Respiratory Disease 138: 1510-1514.
13. O'Donnell DE, Voduc N, Fitzpateick M, Webb KA. (2004) Effect of salmoterol on the ventilatory response to exercise in chronic obstructive pulmonary disease. European Respiratory Journal 24: 86-94.
14. O'Donnell DE, Webb KA. (2008) The major limitation to exercise performance in COPD is dynamic hyperinflation. Journal of Applied Physiology 105: 753-755.
15. Padkao T, Jones CU, Boonsawat W. (2008) The effects of a new positive expiratory pressure device on dynamic hyperinflation in a patient with COPD: a controlled case study The 6th Pan-Pacific Conference on Rehabilitation 1: 79.
16. Petrof BJ, Calderini E, Gottfried SB. (1990) Effect of CPAP on respiratory effort and dyspnea during exercise in severe COPD. Journal of Applied Physiology 69: 179-188.
17. Plant PK, Owen JL, Elliott MW. (2000) Early use of noninvasive ventilation for acute exacerbations of chronic obstructive pulmonary disease on general respiratory wards: a multicentre randomised controlled trial. The Lancet 355: 1931-1935.
18. Rabe KF, Hurd S, Anzueto A, Barnes PJ, Buist SA, Calverley P et al. (2007) Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. American Journal of Respiratory and Critical Care Medicine 176: 532-555.
19. Spalding TW, Lyon LA, Steel DH, Hatfield BD. (2004) Aerobic exercise training and cardiovascular reactivity to psychological stress in sedentary young normotensive men and women. Psychophysiology 41: 552-562.
20. Spahija J, de Marchie M, Grassino A. (2005) Effects of imposed pursed-lips breathing on respiratory mechanics and dyspnea at rest and during exercise in COPD. Chest 128: 640-650.
21. Spruit MA, Gosselink R, Troosters T, De Paepe K, Decramer M. (2002) Resistance versus endurance training in patients with copd and peripheral muscle weakness. European Respiratory Journal 19: 1072-1078.
22. van der Schans CP, de Jong W, de Vries G, Kaan WA, Postma DS, Koeter GH et al. (1994) Effects of positive expiratory pressure breathing during exercise in patients with COPD. Chest 105: 782-789.
23. van der Schans CP, de Jong W, Kort E, Wijkstra PJ, Koeter GH, Postma DS et al. (1995) Mouth pressures during pursed lip breathing. Chest 11: 29-34.
24. Weng JT, Smith DE, Graybar GB, Kirby RR. (1984) Hypotension secondary to air trapping treated with expiratory flow retard. Anesthesiology 60: 350-353.
25. Wouters EFM. (2006) Nonpharmacological modulation of dynamic hyperinflation. European Respiratory Review 15: 90-96.